LINC Asia‑Pacific 2016

LINC Asia-Pacific is a multidisciplinary, educational course covering all fields of peripheral arterial interventions including carotid, renal, femoral, below the knee procedures as well as stent-grafting for AAA, TAA and aortic dissections. The course is practice oriented, with special emphasis on complex revascularization techniques and interdisciplinary discussion.

Leipzig Interventional Course

LINC 2016, the Leipzig Interventional Course, will feature state-of-the-art lectures and numerous live cases performed from leading interventional centers.

GE Healthcare showed its latest software solutions for data analytics and dose monitoring at the 2015 Radiological Society of North America (RSNA) annual meeting, Nov. 29-Dec. 3 in Chicago.

Valentin Fuster, M.D., Ph.D., director of Mount Sinai Heart and physician-in-chief of The Mount Sinai Hospital, joined a panel of international experts at the United Nations where he spoke about promoting cardiovascular health worldwide and how the practice of medicine will change to reflect an increase in ambulatory care.

The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III trial (ROCKET AF) of the oral anticoagulant rivaroxaban. The analysis was prompted by a December 2014 U.S. Food and Drug Administration (FDA) recall of a device used in the study.

ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS Gen II). The EOS is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.

Patients with in-hospital cardiac arrest (IHCA) have low survival rates—but why do some hospitals achieve higher survival than others?

Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from Essential Medical successfully closed large bore arterial access without complication.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now